EyeSonix

EyeSonix | Redefining Glaucoma Care with Non-Invasive Ultrasound Mission At EyeSonix, our mission is to transform glaucoma care by shifting from reactive treatment to proactive preservation of vision. Our innovative, non-invasive ultrasound therapy is designed to offer patients a comfortable, effective, and repeatable option to lower intraocular pressure and protect optic nerve health. About Us EyeSonix was founded on a pivotal insight: ultrasound, long used in cataract surgery, demonstrated an additional therapeutic benefit—lowering intraocular pressure. Building on this observation, we are developing a proprietary, low-power ultrasound device designed specifically for glaucoma treatment. Supported by published clinical studies, strong intellectual property, and an experienced leadership team, we are advancing what could become a new standard of care for patients worldwide. The Need for Change Current glaucoma management often follows a reactive pathway: eyedrops, then lasers, and finally invasive surgery if progression continues. Each approach has well-known limitations: Pharmaceuticals (eyedrops): compliance challenges, side effects, and irritation Laser therapies: limited repeatability and costly infrastructure Invasive surgery: risks of infection, complications, and vision loss—typically reserved for advanced disease EyeSonix aims to provide a new paradigm: a safe, comfortable, and repeatable treatment that empowers physicians and patients to proactively manage glaucoma and preserve vision before irreversible damage occurs.

• Employees 2
• Founded 2006